EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 42 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,788 | -36.8% | 3,108 | 0.0% | 0.00% | – |
| Q4 2022 | $4,413 | -80.8% | 3,108 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $23,000 | +76.9% | 3,108 | +50.3% | 0.00% | 0.0% |
| Q2 2022 | $13,000 | -23.5% | 2,068 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $17,000 | +54.5% | 2,068 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -21.4% | 2,068 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $14,000 | -22.2% | 2,068 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $18,000 | 0.0% | 2,068 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $18,000 | -28.0% | 2,068 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $25,000 | +47.1% | 2,068 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $17,000 | -15.0% | 2,068 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $20,000 | +42.9% | 2,068 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $14,000 | -54.8% | 2,068 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $31,000 | +47.6% | 2,068 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $21,000 | -4.5% | 2,068 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $22,000 | +633.3% | 2,068 | +665.9% | 0.00% | – |
| Q1 2017 | $3,000 | – | 270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $14,118,000 | 3.56% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $12,637,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $3,044,000 | 0.52% |
| Boxer Capital, LLC | 138,331 | $1,093,000 | 0.26% |
| DAFNA Capital Management LLC | 35,977 | $284,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 223,100 | $1,762,000 | 0.12% |
| Hikari Power Ltd | 60,992 | $482,000 | 0.06% |
| Perceptive Advisors | 157,679 | $1,245,000 | 0.06% |
| Lombard Odier Asset Management (USA) Corp | 90,000 | $711,000 | 0.06% |
| TFS CAPITAL LLC | 12,128 | $96,000 | 0.04% |